RPRX stock news
This page provides real-time market news, earnings updates, and company announcements related to Royalty Pharma plc (RPRX).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-27 11:36 EST
Texas Pacific Land (TPL) Hits New Records in Q4 2025
Finviz2026-02-23 15:54:44
Black Stone Minerals: Fourth Quarter Earnings Overview
101 finance2026-02-23 23:00:45
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-02-24 12:09:09
BridgeBio Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial Updates
Finviz2026-02-24 21:06:47
Cardiff Oncology Reports Full Year 2025 Results and Provides Business Update
Finviz2026-02-24 21:33:13
Cardiff Oncology Reports Full Year 2025 Results and Provides Business Update
Finviz2026-02-24 21:33:13
Zacks Begins Analysis of Regis, Suggests a Neutral Stance
101 finance2026-02-25 15:09:44
CEVA's UBS Buy Initiation: A Tactical Re-rating Play with Apple Modem Catalyst
101 finance2026-02-25 21:12:54
Arm Surges 2.81% Despite 218th-Ranked Volume Amid Institutional Jitters and Analyst Optimism
101 finance2026-02-25 23:27:42
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
Finviz2026-02-26 12:03:46
Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results
Finviz2026-02-26 12:33:47
BeiGene Q4 Revenue Up 33% Year-on-Year, Achieves Annual Profitability; Brukinsa Posts Record High Single-Quarter Sales of 1.1 Billion | Earnings Report Highlights
华尔街见闻2026-02-26 12:57:15
MannKind Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 13:03:43
Unleashing Xeris Biopharma's (XERS) Q4 Opportunities: Analyzing Wall Street Projections for Essential Metrics
101 finance2026-02-26 15:19:12
VNOM Q4 Results Surpass Expectations Due to Increased Output
101 finance2026-02-26 17:27:42
Galiano Gold (GAU) Achieves Record Q4 Revenue as Production Surges 15%
Finviz2026-02-26 19:33:10
Global Strategic's $8 Million Wager: Savvy Investment Move or Potential Insider Pitfall?
101 finance2026-02-26 20:54:42
Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 21:03:45
Denali Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Finviz2026-02-26 21:03:46
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results
Finviz2026-02-26 21:09:42
Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook
Finviz2026-02-26 21:09:43
Nexa Resources Reports Adjusted EBITDA of US$772 Million, and US$223 Million Net Income in 2025
Finviz2026-02-26 21:27:03
Xponential Fitness (NYSE:XPOF) Exceeds Q4 CY2025 Expectations But Stock Drops 10.3%
Finviz2026-02-26 22:00:47
European Wax Center (EWCZ) Q4 Results Approaching: Experts Share Perspectives on Crucial Performance Indicators
101 finance2026-02-27 15:18:45
Cardiff Oncology Reports Full Year 2025 Results and Provides Business Update
Finviz2026-02-24 21:33:13
Cardiff Oncology Reports Full Year 2025 Results and Provides Business Update
Finviz2026-02-24 21:33:13
Zacks Begins Analysis of Regis, Suggests a Neutral Stance
101 finance2026-02-25 15:09:44
CEVA's UBS Buy Initiation: A Tactical Re-rating Play with Apple Modem Catalyst
101 finance2026-02-25 21:12:54
Arm Surges 2.81% Despite 218th-Ranked Volume Amid Institutional Jitters and Analyst Optimism
101 finance2026-02-25 23:27:42
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
Finviz2026-02-26 12:03:46
Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results
Finviz2026-02-26 12:33:47
BeiGene Q4 Revenue Up 33% Year-on-Year, Achieves Annual Profitability; Brukinsa Posts Record High Single-Quarter Sales of 1.1 Billion | Earnings Report Highlights
华尔街见闻2026-02-26 12:57:15
MannKind Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 13:03:43
Unleashing Xeris Biopharma's (XERS) Q4 Opportunities: Analyzing Wall Street Projections for Essential Metrics
101 finance2026-02-26 15:19:12
VNOM Q4 Results Surpass Expectations Due to Increased Output
101 finance2026-02-26 17:27:42
Galiano Gold (GAU) Achieves Record Q4 Revenue as Production Surges 15%
Finviz2026-02-26 19:33:10
Global Strategic's $8 Million Wager: Savvy Investment Move or Potential Insider Pitfall?
101 finance2026-02-26 20:54:42
Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 21:03:45
Denali Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Finviz2026-02-26 21:03:46
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results
Finviz2026-02-26 21:09:42
Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook
Finviz2026-02-26 21:09:43
Nexa Resources Reports Adjusted EBITDA of US$772 Million, and US$223 Million Net Income in 2025
Finviz2026-02-26 21:27:03
Xponential Fitness (NYSE:XPOF) Exceeds Q4 CY2025 Expectations But Stock Drops 10.3%
Finviz2026-02-26 22:00:47
European Wax Center (EWCZ) Q4 Results Approaching: Experts Share Perspectives on Crucial Performance Indicators
101 finance2026-02-27 15:18:45
RPRX stock chart
RPRX stock detailsRPRX stock price change
On the last trading day, RPRX stock closed at 45.15 USD, with a price change of -0.55% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more